Quaker Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,952
Closed -$100K 1472
2025
Q1
$100K Buy
+3,952
New +$103K 0.04% 102

Other funds holding PFE

Quaker Wealth Management's PFE Position: Q2 2026 in Review

Quaker Wealth Management increased its Pfizer (PFE) stake by 0.36% in Q2 2026, buying an estimated $340 and bringing the position to 3,608 shares worth $86.9K. The position accounts for 0.03% of the portfolio, ranked #120.

Quaker Wealth Management first reported a position in PFE in Q4 2019 and has held it in 14 quarters since. The position peaked at $462K in Q4 2020. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Quaker Wealth Management held 3,608 shares of Pfizer worth $86.9K as of Q2 2026.
  • Quaker Wealth Management bought 13 Pfizer shares in Q2 2026, an estimated $340.
  • Pfizer made up 0.03% of Quaker Wealth Management's portfolio in Q2 2026, its #120 holding.
  • Quaker Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 14 quarters since.
  • Quaker Wealth Management's Pfizer position peaked at $462K in Q4 2020.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.